Zobrazeno 1 - 10 of 29 pro vyhledávání: '"E. V. Degterev"'
1
Issues Related to Patent Protecton of Darunavir and its Analogs
Autor: A. O. Popova, A. A. Kamalova, S. A. Zaitsev, D. L. Shobolov, K. Yu. Suponitskii, M. S. Goizman, Alexander A. Korlyukov, E. V. Degterev, O. A. Zotova, N. L. Shimanovskii
Publikováno v: Pharmaceutical Chemistry Journal. 50:413-418
It is shown that prolongation of patent protection for the antiviral drug darunavir by patenting it again as darunavir ethanolate is illegal. The claims of the successor patent “Pseudopolymorphic forms of a HIV protease inhibitor,” WO 2003106461
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::950cc138ce5c815fb91103338b045ae0
https://doi.org/10.1007/s11094-016-1461-7
Zobrazit plný text záznamu
2
Physicochemical, Terminological, and Ethical Aspects of the Patenting of Substances and Medicinal Formulations of Abacavir Sulfate
Autor: Alexander A. Korlyukov, K. Yu. Suponitskii, A. A. Kamalova, M. S. Goizman, T. É. Balayants, A. O. Popova, E. V. Degterev, S. A. Zaitsev, S. Kh. Papikyan, A. S. Trifilenkov, A. S. Berlyand, N. L. Shimanovskii
Publikováno v: Pharmaceutical Chemistry Journal. 49:65-72
Using abacavir sulfate substance and medicinal formulations as an example, this being an agent used as an active pharmaceutical substance (APS) protected by a series of patents, we demonstrate that additional patenting has occurred because its physic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7c49d994cdc0b9ed56148d9851d47834
https://doi.org/10.1007/s11094-015-1223-y
Zobrazit plný text záznamu
3
The Atropomer Composition of Iopromide as an Indicator for Assessment of the Quality of its Substance and Medincal Formulations
Autor: N. N. Demidova, D. E. Dmitriev, Dmitry E. Arkhipov, D. A. Arantseva, A. S. Trifilenkov, M. B. Zagudailova, M. S. Goizman, E. V. Degterev, N. L. Shimanovskii, R. G. Glushkov, K. Yu. Suponitskii, Alexander A. Korlyukov, E. K. Kulaeva, S. A. Zaitsev
Publikováno v: Pharmaceutical Chemistry Journal. 48:186-195
The atropisomer composition of iopromide substance and formulations is discussed. At 120 °C in aqueous iopromide solution, its atropisomers were found to be converted to conformers, which reached equilibrium with each other in 15 min at this tempera
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dcd3b612b6167ddaf5c746f67791118b
https://doi.org/10.1007/s11094-014-1075-x
Zobrazit plný text záznamu
4
Optimizing Quality Control of Docetaxel Drug Substance and its Parenteral Dosage Forms
Autor: M. G. Chernobrovkin, M. S. Goizman, E. K. Kulaeva, E. V. Degterev, D. A. Arantseva, M. B. Zagudailova, I. I. Demidova
Publikováno v: Pharmaceutical Chemistry Journal. 47:503-508
An HPLC method for quantitative determination of docetaxel and impurities in docetaxel drug substance and related dosage forms was developed for their quality control. Validation of the proposed method during the course of drug analysis stipulated se
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5ff37abb1a7cef2013e7492866d483dc
https://doi.org/10.1007/s11094-013-0990-6
Zobrazit plný text záznamu
6
Pharmacokinetics of ximedone
Autor: M. I. Evgen'ev, V. I. Pogorel'tsev, S. Yu. Garmonov, E. V. Degterev, V. S. Reznik
Publikováno v: Pharmaceutical Chemistry Journal. 40:349-352
Optimum conditions for the spectrophotometric determination of pyrimidine derivatives in biological fluids of humans are determined. This method has been used for the investigation of the pharmacokinetics of the new immunomodulant ximedone in humans,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f870a11e675fe6d68527cabc52bae1c4
https://doi.org/10.1007/s11094-006-0125-4
Zobrazit plný text záznamu
7
Effect of the immunomodulant ximedone on the pharmacokinetics of isonicotinic acid hydrazide in the human organism
Autor: M. I. Evgen'ev, N. S. Shitova, E. V. Degterev, T. A. Kiseleva, S. Yu. Garmonov, V. I. Pogorel’tsev
Publikováno v: Pharmaceutical Chemistry Journal. 40:119-123
The pharmacokinetics of isonicotinic acid hydrazide upon joint administration with the immunomodulant ximedone has been investigated. Ximedone influences the genetically determined parameters of the isonicotinic acid hydrazide pharmacokinetics. The d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::689746e17e0b09678ecdffccdcdc835b
https://doi.org/10.1007/s11094-006-0073-z
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje